Ankylosing spondylitis and systemic lupus erythematosus: a rare HLA combination
Nashel, D.J.; Leonard, A.; Mann, D.L.; Guccion, J.G.; Katz, A.L.; Sliwinski, A.J.
Archives of Internal Medicine 142(6): 1227-1228
1982
ISSN/ISBN: 0003-9926 PMID: 7092432 Document Number: 188664
The condition of a 43-year-old man fulfilled the strict diagnostic criteria for both ankylosing spondylitis and systemic lupus erythematosus. To our knowledge, this is the fist verified report of the concurrence of these rheumatic diseases. An unusual combination of genetically determined markers seems to have caused an increased risk for the development of both disorders.
Document emailed within 1 workday
Related Documents
Dubois, E.L.; Chandor, S.; Friou, G.J.; Bischel, M. 1971: Progressive systemic sclerosis and localized scleroderma morphea with positive lupus erythematosus cell test and unusual systemic manifestations compatible with systemic lupus erythematosus presentation of 14 cases including 1 set of identical twins 1 with scleroderma and the other with systemic lupus erythematosus review of the literature Medicine (Baltimore) 50(3): 199-222Carr, R.; Forsyth, S.; Sadi, D. 1987: Abnormal responses to ingested substances in murine systemic lupus erythematosus: apparent effect of a casein-free diet on the development of systemic lupus erythematosus in NZB/W mice Journal of Rheumatology. Suppl 14(Suppl 13): 158-165
Grazio, S.; Grubisić, F.; Nemcić, T.; Matijević, V.; Skala, H. 2009: The reliability and validity of a Croatian version of the Bath Ankylosing Spondylitis Functional Index (BASFI) and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) in patients with ankylosing spondylitis Reumatizam 56(2): 63-76
Sb, S.; M, S.Kumar.; V, S.Kumar. 2020: Rare Initial Presentations of Systemic Lupus Erythematosus - A Case Series Journal of the Association of Physicians of India 68(1): 79
Barberán López, J.; Khorrami Mashhadi, S.; Sánchez Artola, B.; Menéndez, M.A.; Pérez de Oteyza, C. 1999: Pleurisy in an aged patient: a rare presentation of systemic lupus erythematosus Anales de Medicina Interna 16(6): 324-325
Arunkumar, S.; Vinod, K.V.; Verma, S.P.; Dutta, T.K. 2014: Cardiac tamponade: a rare presenting manifestation of systemic lupus erythematosus National Medical Journal of India 27(5): 294-295
Gupta, A.; Chandra, N.; Kler, T.S. 2002: Aortoarteritis with systemic lupus erythematosus and secondary antiphospholipid antibody syndrome: a rare association Indian Heart Journal 54(3): 301-303
Lorenzoni, P.José.; Scola, R.H.; Kay, Cáudia.S.K.; Novak, F.T.M.; Cardoso, E.H.; Scalcon, Márcia.R.R.; Rachid Filho, A.; Werneck, L.C. 2011: Isolated hypoglossal nerve palsy: an unusual rare presentation in systemic lupus erythematosus Arquivos de Neuro-Psiquiatria 69(5): 843-844
Sieper, J.; Braun, J. 2002: New treatment strategies in ankylosing spondylitis: Proceedings of the Ankylosing Spondylitis Workshop, Berlin, Germany, 18-19 January 2002 Annals of the Rheumatic Diseases 61 Suppl. 3: Iii1-Iii2
Ames, P.R.; Lubrano, E.; Scarpa, R.; Iannaccone, L.; Brancaccio, V. 1993: Lupus anticoagulant, ankylosing spondylitis, and thrombosis Journal of Rheumatology 20(9): 1626-1628
Rudge, S.R.; Treadwell, B.L. 1980: HLA B27 negative ankylosing spondylitis--a rare condition Australian and New Zealand Journal of Medicine 10(2): 227-229
Fur, A.; Benoit, J.P.; Perrichon, M.; Verges, B.; Camus, P.; Jeannin, L. 1988: A rare cause of bilateral serofibrinous pleurisy: ankylosing spondylitis Presse Medicale 17(19): 963-964
Villa Alcázar, L.F.; de Buergo, M.; Rico Lenza, H.; Montull Fruitós, E. 1996: Aceclofenac is as safe and effective as tenoxicam in the treatment of ankylosing spondylitis: a 3 month multicenter comparative trial. Spanish Study Group on Aceclofenac in Ankylosing Spondylitis Journal of Rheumatology 23(7): 1194-1199
Kim, T.-J.; Shin, J.-H.; Sung, I.-H.; Lee, S.; Song, Y.; Kim, T.-H. 2016: Comparison on radiographic progression for 5 years between juvenile onset ankylosing spondylitis and adult onset ankylosing spondylitis: an observational study of the Korean SpondyloArthropathy Registry (OSKAR) data Clinical and Experimental Rheumatology 34(4): 668-672
Calin, A.; Garrett, S.; Whitelock, H.; Kennedy, L.G.; O'Hea, J.; Mallorie, P.; Jenkinson, T. 1994: A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index Journal of Rheumatology 21(12): 2281-2285
Raleigh-Rosendo, R.; Diez-Ewald, M.; Vizcaíno, G.; Fereira, H.; Arteaga-Vizcaíno, M.; Arreaza, M. 1990: Presence of lupus-type anticoagulant, in systemic lupus erythematosus and other clinical entities Investigacion Clinica 31(1): 45-55
Engelsen, J.; Nielsen, S.M.; Thorsen, S. 2006: Serious bleeding in systemic lupus erythematosus complicated by lupus anticoagulant-hypoprothrombinaemia syndrome Ugeskrift for Laeger 168(5): 486-487
Johns, A.S.; Chamley, L.; Ockelford, P.A.; Pattison, N.S.; McKay, E.J.; Corkill, M.; Hart, H. 1994: Comparison of tests for the lupus anticoagulant and antiphospholipid antibodies in systemic lupus erythematosus Clinical and Experimental Rheumatology 12(5): 523-526
Destée, A.; Devos, P.; Prin, L.; Warot, M.; Warot, P. 1985: Brain stem infarction, systemic lupus erythematosus and circulating lupus anticoagulant Revue Neurologique (Paris) 141(3): 236-239
Asherson, R.A.; Lanham, J.G.; Hull, R.G.; Boey, M.L.; Gharavi, A.E.; Hughes, G.R. 1984: Renal vein thrombosis in systemic lupus erythematosus: association with the "lupus anticoagulant" Clinical and Experimental Rheumatology 2(1): 75-79